The immune system knows how to stop.

Every immune response has two jobs.

Turn on.

Turn off.

When regulation works, inflammation resolves.

When it does not, the response can persist.

Allergy is not just activation.

It is failed regulation.

That is the idea behind AbstimX™.

Not simply to block what the immune system is doing.

But to influence the system that tells it when to stop.

Most modern therapies target the response

Trigger

Inflammatory response

Target / block

AbstimX™ hypothesis targets regulation

Trigger

Inflammatory response

Regulatory control

The idea is upstream.

AbstimX is investigational. Its mechanism and clinical effects remain under investigation.

Two antibody signals.

One alone is not the idea.

The relationship between them is.

Immunoglobulin signal

+

Antigen-specific immunoglobulin signal

Regulatory interaction

Change in immune response

That interaction is the therapeutic hypothesis.

Why antibodies?

Because antibodies do more than recognize threats.

They also participate in the regulation of immune responses.

AbstimX™ builds on that biology.

Use the language of the immune system to regulate the immune system.

We did not start with a molecule.

We started with a relationship.

AbstimX™ is designed around the interaction between two immunoglobulin signals, rather than a single molecular target.

That relationship is the idea.